Teva Pharmaceuticals
European regulator approves Teva’s $40.5-bn Allergan drug unit deal with conditions
11 Mar 2016
The European Commission yesterday approved Teva Pharmaceutical Industries' $40.5-billion acquisition of the generics drug unit of Allergan on condition that it divests some Allergan products in the UK and Ireland
Teva to buy Mexican drugmaker Rimsa for $2.3 bn
03 Oct 2015
With this acquisition, Teva will become a leading pharmaceutical company in Mexico, the second-largest market in Latin America and one of the top five emerging markets globally
Teva in $40.5-bn pact to buy Allergan's generics, ends Mylan bid
27 Jul 2015
Post-merger, Allergan will have one of the broadest product portfolios and strongest pipelines in the generics industry
Teva in talks to buy Allergan's generic-drug unit for $45 bn: report
27 Jul 2015
A deal with Allergan would indicate that Teva could be considering abandoning its plan to buy Mylan NV after the Netherlands-based company rejected its $40-billion takeover offer
Teva plans to raise bid for rival drugmaker Mylan to $42 bn
07 Jul 2015
Teva and Mylan's product offerings are highly complementary and, together, would create the broadest portfolio in the global pharmaceuticals industry, with a combined pipeline of over 400 applications for new drugs
Teva pressures takeover target Mylan with 1.8% stake buy
03 Jun 2015
Analysts expect Teva to make a sweetened formal bid for Mylan after raising its stake to the 4.6 per cent threshold, because once it tables a formal bid, it cannot buy Mylan shares from the market
Teva settles US antitrust charges for $1.2 bn
29 May 2015
The world’s biggest generic drug maker Israel’s Teva Pharmaceutical Industries has agreed to settle US antitrust charges for illegally blocking competition to its blockbuster sleep-disorder drug Provigil
Teva Pharmaceutical offers to buy Mylan NV for $40 bn
22 Apr 2015
A successful Teva-Mylan merger would be the largest in the pharmaceutical industry this year, which has seen acquisitions taking place at a frenzied pace
